Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome

Journal of the American Academy of Dermatology

Volumn 53, Issue 3, 2005, Pages 428-434

  Introcaso, Camille E ^a   Hess, Stephen D ^a   Kamoun, Malek ^a   Ubriani, Ravi ^a   Gelfand, Joel M ^a   Rook, Alain H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 2 Rhoads Pavilion ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIPEPTIDYL PEPTIDASE IV;

ADULT; AGED; CELL POPULATION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEZARY SYNDROME; T LYMPHOCYTE;

EID: 23944516596     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.06.001     Document Type: Article

References (17)

1. L. Kari, A. Loboda, M. Nebozhyn, A.H. Rook, E.C. Vonderheid, and C. Nichols Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma J Exp Med 197 2003 1477 1488
2. Y.H. Kim, H.L. Liu, S. Mraz-Gernhard, A. Varghese, and R.T. Hoppe Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression Arch Dermatol 139 2003 857 866
3. A. Rook, R. Suchin, D. Kao, E. Yoo, B. Macey, and B. DeNardo Photopheresis: clinical applications and mechanism of action J Invest Dermatol 4 1999 85 90
4. M. Girardi, P. Heald, and L. Wilson The pathogenesis of mycosis fungoides N Engl J Med 350 2004 1978 1988
5. M. Duvic, N. Apisarnthanarax, D. Cohen, T. Smith, C. Ha, and R. Kurzrock Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma J Am Acad Dermatol 49 2003 35 49
6. R. Winkelmann, and J. Linman Erythroderma with atypical lymphocytes (Sezary syndrome) Am J Med 55 1973 192 198
7. D. Jones, N. Dang, and M. Duvic Absence of CD26 expression is a useful marker for diagnosis of T cell lymphoma in peripheral blood Am J Clin Pathol 115 2002 885 892
8. G. Wood, R. Tung, A. Haeffner, C. Crooks, S. Liao, and R. Orozco Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE) J Invest Dermatol 103 1994 34 41
9. M. Bernengo, P. Quaglino, M. Novelli, N. Cappello, G. Doveil, and F. Lisa Prognostic factors in Sezary syndrome: a multivariate analysis of clinical, haematological and immunological features Ann Oncol 9 1998 857 863
10. E. Scala, G. Russo, S. Cadoni, M. Narducci, C. Girardelli, and O. DePita Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion J Invest Dermatol 113 1999 622 627
11. E. Vonderheid, R. Bigler, A. Kotecha, C. Boselli, S. Lessin, and M. Bernengo Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome) J Invest Dermatol 117 2002 654 662
12. M. Bernengo, M. Novelli, P. Quaglino, F. Lisa, A. DeMatteis, and P. Savoia The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells Br J Dermatol 144 2001 125 135
13. M. Willheim, C. Ebner, K. Baier, W. Kern, K. Schrattbauer, and R. Thien Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets J Allergy Clin Immunol 100 1997 348 355
14. U. Aytac, and N. Dang CD26/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy Curr Drug Targets Immune Endocr Metabol Disord 4 2004 11 18
15. B. Vowels, M. Cassin, E. Vonderheid, and A. Rook Aberrant cytokine production by Sezary syndrome patients: cytokine secretion resembles murine Th2 cells J Invest Dermatol 99 1992 90 94
16. E. Vonderheid, M. Bernengo, G. Burg, M. Duvic, P. Heald, and L. Laroche Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas J Am Acad Dermatol 46 2002 95 106
17. P. Quaglino, M. Fierro, G. Rossotto, P. Savoia, and M. Bernengo Treatment of advanced mycosis fungoides/Sezary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy Br J Dermatol 150 2004 327 336